We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness and Costs of Enhanced Cocaine Treatments

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00167258
First Posted: September 14, 2005
Last Update Posted: December 15, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Pennsylvania
September 9, 2005
September 14, 2005
December 15, 2009
Not Provided
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00167258 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Effectiveness and Costs of Enhanced Cocaine Treatments
Not Provided
The study will evaluate the effectiveness, economic benefits, and costs of voucher reinforcement for cocaine and alcohol abstinence, additional counseling services, and their combination in a sample of cocaine dependent patients receiving outpatient treatment as usual in a community clinic.
Not Provided
Interventional
Phase 2
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Cocaine Dependence
  • Behavioral: Voucher Reinforcement
  • Behavioral: Extra Counseling Services
  • Behavioral: Voucher Reinforcement + Extra Counseling Services
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
February 2007
Not Provided

Inclusion Criteria:

  • Enrollment in an intensive outpatient program (IOP) for no more than 1 month
  • Current DSM-IV diagnosis of cocaine dependence (month prior to IOP treatment)
  • 18-65 years of age
  • Ability to provide names of informants to help locate subject for follow-up

Exclusion Criteria:

  • IV heroin use in last year
  • Acute medical/psychiatric diagnosis that precludes outpatient treatment
  • Inpatient treatment for 6 weeks or more prior to IOP treatment
  • Incarceration for 6 months or more prior to IOP treatment
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
Not Provided
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00167258
702110
Not Provided
Not Provided
Not Provided
Dr. James McKay, University of Pennsylvania
University of Pennsylvania
Not Provided
Principal Investigator: James R McKay, PhD University of Pennsylvania
University of Pennsylvania
December 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP